Kern Winfried V, Fätkenheuer Gerd, Tacconelli Evelina, Ullmann Andrew
Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg, Germany.
Klinik I für Innere Medizin, Universitätsklinikum Köln, Germany.
Z Evid Fortbild Qual Gesundhwes. 2015;109(7):493-9. doi: 10.1016/j.zefq.2015.09.015. Epub 2015 Oct 30.
Clinical infectious diseases have only slowly been established as a medical specialty in Germany. The density of infectious diseases (ID) specialists and the number of ID divisions in general hospitals is still limited when compared with the situation in many other European countries, and there is also a lack of hospital-based medical microbiologists and infection control doctors for many reasons. Often, there is a lack of understanding of the roles and the performance of ID specialists versus microbiologists. Experience in other countries shows that ID specialists are important as clinical experts at the bedside, can help ascertain healthcare quality and patient safety, and are perfectly suited for undertaking strategic tasks in the field of cost-effective antimicrobial therapy algorithms and antibiotic stewardship (ABS) in hospitals. ID specialists are responsible for infection control in several countries, can improve the utility of diagnostic microbiology and are key partners in translational research. We estimate that more than 1,000 additional ID specialists are needed in this country, and believe that specially trained ABS experts can take over parts of their responsibilities and tasks in smaller hospitals. More capacity and flexibility in postgraduate training in infectious diseases, antibiotic stewardship and infection control in Germany will be critical to address the problem of antimicrobial resistance. (As supplied by publisher).
在德国,临床传染病学作为一门医学专科的发展较为缓慢。与许多其他欧洲国家的情况相比,传染病(ID)专科医生的密度以及综合医院中ID科室的数量仍然有限,而且由于多种原因,医院内医学微生物学家和感染控制医生也很短缺。人们常常对ID专科医生与微生物学家的角色和工作表现缺乏了解。其他国家的经验表明,ID专科医生作为床边临床专家很重要,有助于确定医疗质量和患者安全,非常适合承担医院中具有成本效益的抗菌治疗方案和抗生素管理(ABS)领域的战略任务。在一些国家,ID专科医生负责感染控制,能够提高诊断微生物学的效用,并且是转化研究的关键合作伙伴。我们估计,德国还需要1000多名ID专科医生,并且认为经过专门培训的ABS专家可以在较小的医院承担他们的部分职责和任务。德国在传染病、抗生素管理和感染控制方面的研究生培训增加更多能力和灵活性对于解决抗菌药物耐药性问题至关重要。(由出版商提供)